4547 キッセイ薬品工業

4547
2026/01/20
時価
2182億円
PER 予
15.31倍
2010年以降
7.23-53.23倍
(2010-2025年)
PBR
0.92倍
2010年以降
0.43-1.25倍
(2010-2025年)
配当 予
2.56%
ROE 予
6.01%
ROA 予
4.86%
資料
Link
CSV,JSON

イベントチャート

2025/08/21~2026/01/20

イベント情報&株価推移

日付始値高値安値終値前日比出来高時価総額25日乖離
2026
01/204,6754,6954,6454,690+0.21%43,3002182億8190万+0.77%
01/194,7304,7304,6754,680-0.95%37,2002178億1648万+0.62%
01/164,6904,7254,6504,7250%36,4002199億1087万+1.68%
01/154,7254,7754,7104,7250%45,0002199億1087万+1.81%
01/144,7654,7904,7054,725-0.84%46,5002199億1087万+2.01%
01/134,7804,8154,7554,765-0.31%46,4002217億7255万+3%
01/094,8004,8054,7404,780+0.53%78,9002224億7068万+3.53%
01/084,7004,7804,6854,755+2.26%102,1002213億713万+3.12%
01/074,5704,7054,5704,650+0.87%97,3002164億2023万+0.93%
01/064,6104,6404,5954,610-0.11%47,8002145億5855万+0.04%
01/054,6204,6454,5854,615-0.75%45,5002147億9126万+0.11%
2025
12/304,6704,6704,5904,650+1.09%53,7002164億2023万+0.87%
12/294,6104,6104,5654,600-0.22%46,9002140億9313万-0.15%
12/264,6104,6304,5804,610-0.75%41,0002145億5855万+0.11%
12/254,6754,6754,6104,645+0.22%46,7002161億8752万+1.11%
12/244,6354,6554,6054,6350%46,0002157億2210万+1.22%
12/234,5804,6354,5704,635+1.53%39,4002157億2210万+1.6%
12/22(IR情報)15:30 GnRHアンタゴニスト「イセルティ錠100mg」の子宮筋腫を適応症とした国内製造販売承認取得のお知らせ
12/224,6054,6054,5154,565-0.98%45,9002124億6416万+0.46%
12/194,6304,6504,6104,610-0.97%41,6002145億5855万+1.83%
12/184,6504,6754,6354,655+0.32%51,5002166億5294万+3.26%
12/174,6404,6504,5754,640+0.54%49,5002159億5481万+3.41%
12/164,5904,6354,5704,615+0.44%65,9002147億9126万+3.36%
12/154,6054,6354,5204,595+0.33%83,0002138億6042万+3.4%
12/124,6504,6704,5654,580-0.11%56,8002131億6229万+3.6%
12/114,6604,6604,5504,585-0.97%46,3002133億9500万+4.25%
12/104,5804,6604,5704,630+0.98%38,2002154億8939万+5.83%
12/094,5854,6104,5354,585+0.22%47,7002133億9500万+5.4%
12/084,5354,6054,5304,575+1.89%45,2002129億2958万+5.71%
12/054,5104,5304,4154,490-1.64%67,7002089億7351万+4.32%
12/044,5504,5854,5304,565+0.33%48,7002124億6416万+6.56%
12/034,5754,6054,5504,550-1.73%74,0002117億6603万+6.68%
12/024,6304,6604,5404,630-0.32%65,0002154億8939万+8.92%
12/01(IR情報)15:30 配当支払開始予定日の変更に関するお知らせ
12/014,6854,7254,6304,645-1.06%81,2002161億8752万+9.78%
11/284,6604,7804,6354,695+0.86%89,3002185億1461万+11.44%
11/274,6104,6554,6004,655+1.2%67,1002166億5294万+11.07%
11/264,5804,6104,5604,600+0.44%105,9002140億9313万+10.29%
11/254,5104,5854,4904,580+0.66%112,0002131億6229万+10.26%
11/214,3704,5504,3704,550+4.72%147,7002117億6603万+10.01%
11/204,3254,3654,2904,345+2%90,0002022億2492万+5.44%
11/194,2304,2754,2204,260+1.07%81,5001982億6885万+3.6%
11/184,1454,2304,1454,215+0.84%63,4001961億7446万+2.65%
11/174,1404,2004,1404,180+0.97%78,9001945億4549万+1.8%
11/144,1354,1704,1054,140+0.12%50,9001926億8381万+0.73%
11/134,1304,1604,1104,135+0.12%63,7001924億5110万+0.49%
11/124,1404,1804,1104,130+0.98%74,5001922億1839万+0.24%
11/114,0904,1054,0104,090-0.12%46,8001903億5671万-0.85%
11/104,0204,1454,0104,095+1.87%103,9001905億8942万-0.87%
11/074,0054,0203,9754,020+0.12%61,6001870億9877万-2.8%
11/063,9754,0753,9604,015+0.12%141,0001868億6606万-3.14%
11/05(IR情報)16:00 2026年3月期第2四半期(中間期)決算説明会資料
11/053,8604,0753,8354,010+0.25%162,3001866億3335万-3.54%
11/04(IR情報)15:30 業績予想の修正に関するお知らせ
11/04(IR情報)15:30 2026年3月期第2四半期(中間期)決算補足資料
11/04(IR情報)15:30 2026年3月期第2四半期(中間期)決算短信〔日本基準〕(連結)
11/043,9804,0403,9554,000-0.62%84,5001861億6794万-4.1%
10/313,9754,0303,9704,025+0.88%67,9001873億3148万-3.92%
10/304,0104,0103,9503,990+0.5%90,2001857億252万-5.14%
10/294,0804,0953,9703,970-3.17%66,4001847億7168万-5.99%
10/284,1904,1904,1004,100-2.26%39,6001908億2213万-3.37%
10/274,1404,1954,1404,195+1.33%38,8001952億4362万-1.46%
10/244,2004,2154,1354,140-1.19%53,7001926億8381万-2.93%
10/23(IR情報)15:30 「リンザゴリクス」の台湾における販売承認取得について
10/234,1754,2204,1504,190+0.84%42,7001950億1091万-1.99%
10/224,1404,1804,1404,155+0.36%52,9001933億8194万-3.08%
10/214,1654,1754,1404,140-0.72%45,3001926億8381万-3.7%
10/204,1754,1854,1404,170+0.6%36,8001940億8007万-3.36%
10/174,1704,1904,1354,145-0.6%40,0001929億1652万-4.27%
10/164,1704,1704,1004,170+0.97%43,1001940億8007万-4.03%
10/154,1254,1504,1204,130+0.61%56,4001922億1839万-5.28%
10/144,1304,1654,0854,105-2.26%58,7001910億5484万-6.21%
10/104,2454,2854,2004,200-1.98%55,2001954億7633万-4.37%
10/094,2554,2904,2554,285+0.47%40,6001994億3240万-2.7%
10/084,2904,3454,2654,2650%58,9001985億156万-3.22%
10/07(IR情報)15:30 「リンザゴリクス」のサーチライトファーマ社(カナダ)への技術導出契約締結に関するお知らせ
10/074,2604,2854,2554,265+0.12%49,9001985億156万-3.29%
10/064,2804,3104,2454,260+0.71%76,4001982億6885万-3.45%
10/034,2204,2554,1754,230+0.24%54,3001968億7259万-4.17%
10/024,2554,2604,1504,220-0.82%81,4001964億717万-4.46%
10/014,2854,2854,2104,255-1.05%85,6001980億3614万-3.73%
09/304,3104,3504,2554,300-1.83%58,5002001億3053万-2.71%
09/294,4254,4304,3654,380-1.46%59,7002038億5389万-0.93%
09/264,4204,4604,4204,445-0.11%75,0002068億7912万+0.61%
09/25(IR情報)15:30 投資有価証券の売却(結果)に関するお知らせ
09/254,4704,4754,4254,450+0.68%50,7002071億1183万+0.84%
09/244,4904,5154,4204,420-0.9%66,3002057億1557万+0.25%
09/224,4454,4804,4104,460+0.34%51,6002075億7725万+1.25%
09/194,4054,4504,3804,445+0.91%169,1002068億7912万+1.07%
09/184,4004,4104,3554,405+0.23%70,5002050億1744万+0.3%
09/174,4204,4254,3604,395-1.79%57,4002045億5202万+0.14%
09/164,4704,4904,4354,475+0.11%70,6002082億7538万+1.98%
09/124,4904,5254,4704,470-1.22%67,2002080億4267万+1.98%
09/114,5354,5604,5004,525-0.55%40,2002106億248万+3.19%
09/104,5304,5704,5004,550+0.44%46,2002117億6603万+3.79%
09/094,5504,5554,5004,530-0.22%80,2002108億3519万+3.42%
09/084,5654,5654,5154,540-0.11%41,9002113億61万+3.72%
09/054,5104,5554,4704,545+1.45%60,6002115億3332万+3.98%
09/044,5504,5504,4804,480-0.33%93,2002085億809万+2.56%
09/034,4104,4954,4104,495+2.63%80,2002092億622万+3.12%
09/024,3454,4304,3454,380+1.27%72,9002038億5389万+0.67%
09/014,3304,3604,3054,3250%38,8002012億9408万-0.51%
08/294,2704,3354,2654,325+0.7%74,1002012億9408万-0.51%
08/284,3004,3204,2654,295-0.35%44,3001998億9782万-1.11%
08/274,2954,3154,2604,310+0.35%72,7002005億9595万-0.65%
08/264,2854,3304,2704,295+0.7%79,2001998億9782万-0.83%
08/254,3004,3104,2654,265-1.5%51,1001985億156万-1.46%
08/224,3054,3304,2804,330+0.93%81,0002015億2679万+0.05%
08/214,3204,3204,2604,290-0.69%59,0001996億6511万-0.74%

IRBANK
公式Xアカウント一覧